Fundies. English
Segment disclosures
Company overviewACETO CORP
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
30 dimension combinations 315 retained observations 32 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · Human Health
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=acet:HumanHealthMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 84981000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 165827000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 80846000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-07-01 – 2018-06-30 | 374514000 | USD | 2018-09-28 · 15:02:38.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 103466000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 209481000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 106015000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2016-07-01 – 2017-06-30 | 315395000 | USD | 2018-09-28 · 15:02:38.000Z | Open filing evidence |
| 2015-07-01 – 2016-06-30 | 228035000 | USD | 2018-09-28 · 15:02:38.000Z | Open filing evidence |
Operating Segments · Performance Chemicals
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=acet:PerformanceChemicalsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 36626000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 81337000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 44711000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-07-01 – 2018-06-30 | 177991000 | USD | 2018-09-28 · 15:02:38.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 34134000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 76798000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 42664000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2016-07-01 – 2017-06-30 | 165478000 | USD | 2018-09-28 · 15:02:38.000Z | Open filing evidence |
| 2015-07-01 – 2016-06-30 | 169478000 | USD | 2018-09-28 · 15:02:38.000Z | Open filing evidence |
Operating Segments · Pharmaceutical Ingredients
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=acet:PharmaceuticalIngredientsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 42042000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 80890000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 38848000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-07-01 – 2018-06-30 | 158854000 | USD | 2018-09-28 · 15:02:38.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 33629000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 70205000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 36576000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2016-07-01 – 2017-06-30 | 157445000 | USD | 2018-09-28 · 15:02:38.000Z | Open filing evidence |
| 2015-07-01 – 2016-06-30 | 161011000 | USD | 2018-09-28 · 15:02:38.000Z | Open filing evidence |
Operating Segments · Human Health
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=acet:HumanHealthMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-03-31 | 91926000 | USD | 2018-10-12 · 21:03:09.000Z | Open filing evidence |
| 2017-07-01 – 2018-03-31 | 301407000 | USD | 2018-10-12 · 21:03:09.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 103466000 | USD | 2018-02-02 · 16:02:38.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 209481000 | USD | 2018-02-02 · 16:02:38.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 106015000 | USD | 2017-11-03 · 19:59:56.000Z | Open filing evidence |
| 2016-07-01 – 2017-06-30 | 315395000 | USD | 2017-11-09 · 22:17:24.000Z | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 99816000 | USD | 2018-10-12 · 21:03:09.000Z | Open filing evidence |
| 2016-07-01 – 2017-03-31 | 201686000 | USD | 2018-10-12 · 21:03:09.000Z | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 53981000 | USD | 2018-02-02 · 16:02:38.000Z | Open filing evidence |
| 2016-07-01 – 2016-12-31 | 101870000 | USD | 2018-02-02 · 16:02:38.000Z | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 47889000 | USD | 2017-11-03 · 19:59:56.000Z | Open filing evidence |
| 2015-07-01 – 2016-06-30 | 228035000 | USD | 2017-11-09 · 22:17:24.000Z | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 58780000 | USD | 2017-05-05 · 16:01:16.000Z | Open filing evidence |
| 2015-07-01 – 2016-03-31 | 175306000 | USD | 2017-05-05 · 16:01:16.000Z | Open filing evidence |
| 2015-10-01 – 2015-12-31 | 59045000 | USD | 2017-02-03 · 17:36:36.000Z | Open filing evidence |
| 2015-07-01 – 2015-12-31 | 116526000 | USD | 2017-02-03 · 17:36:36.000Z | Open filing evidence |
| 2015-07-01 – 2015-09-30 | 57481000 | USD | 20161103 | Open filing evidence |
| 2014-07-01 – 2015-06-30 | 221256000 Restated | USD | 2017-11-09 · 22:17:24.000Z | Open filing evidence |
| 2015-01-01 – 2015-03-31 | 56305000 | USD | 20160506 | Open filing evidence |
| 2014-07-01 – 2015-03-31 | 160808000 | USD | 20160506 | Open filing evidence |
| 2014-10-01 – 2014-12-31 | 55424000 | USD | 20160205 | Open filing evidence |
| 2014-07-01 – 2014-12-31 | 104503000 | USD | 20160205 | Open filing evidence |
| 2014-07-01 – 2014-09-30 | 49079000 | USD | 20151106 | Open filing evidence |
| 2013-07-01 – 2014-06-30 | 160217000 | USD | 20160826 | Open filing evidence |
| 2014-01-01 – 2014-03-31 | 33946000 | USD | 20150508 | Open filing evidence |
| 2013-07-01 – 2014-03-31 | 112457000 | USD | 20150508 | Open filing evidence |
| 2013-10-01 – 2013-12-31 | 39817000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-12-31 | 78511000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-09-30 | 38694000 | USD | 20141107 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 129667000 | USD | 20150911 | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 36299000 | USD | 20140509 | Open filing evidence |
| 2012-07-01 – 2013-03-31 | 92559000 | USD | 20140509 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 29851000 | USD | 20140207 | Open filing evidence |
| 2012-07-01 – 2012-12-31 | 56260000 | USD | 20140207 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 26409000 | USD | 2013-11-08 · 17:00:55.000Z | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 105249000 | USD | 20140905 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 69856000 | USD | 2013-08-29 · 16:01:07.000Z | Open filing evidence |
Operating Segments · Performance Chemicals
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=acet:PerformanceChemicalsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-03-31 | 50871000 | USD | 2018-10-12 · 21:03:09.000Z | Open filing evidence |
| 2017-07-01 – 2018-03-31 | 127669000 | USD | 2018-10-12 · 21:03:09.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 34134000 | USD | 2018-02-02 · 16:02:38.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 76798000 | USD | 2018-02-02 · 16:02:38.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 42664000 | USD | 2017-11-03 · 19:59:56.000Z | Open filing evidence |
| 2016-07-01 – 2017-06-30 | 165478000 | USD | 2017-11-09 · 22:17:24.000Z | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 46491000 | USD | 2018-10-12 · 21:03:09.000Z | Open filing evidence |
| 2016-07-01 – 2017-03-31 | 120759000 | USD | 2018-10-12 · 21:03:09.000Z | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 34755000 | USD | 2018-02-02 · 16:02:38.000Z | Open filing evidence |
| 2016-07-01 – 2016-12-31 | 74268000 | USD | 2018-02-02 · 16:02:38.000Z | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 39513000 | USD | 2017-11-03 · 19:59:56.000Z | Open filing evidence |
| 2015-07-01 – 2016-06-30 | 169478000 | USD | 2017-11-09 · 22:17:24.000Z | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 53305000 | USD | 2017-05-05 · 16:01:16.000Z | Open filing evidence |
| 2015-07-01 – 2016-03-31 | 129298000 | USD | 2017-05-05 · 16:01:16.000Z | Open filing evidence |
| 2015-10-01 – 2015-12-31 | 38334000 | USD | 2017-02-03 · 17:36:36.000Z | Open filing evidence |
| 2015-07-01 – 2015-12-31 | 75993000 | USD | 2017-02-03 · 17:36:36.000Z | Open filing evidence |
| 2015-07-01 – 2015-09-30 | 37659000 | USD | 20161103 | Open filing evidence |
| 2014-07-01 – 2015-06-30 | 172392000 | USD | 2017-11-09 · 22:17:24.000Z | Open filing evidence |
| 2015-01-01 – 2015-03-31 | 48943000 | USD | 20160506 | Open filing evidence |
| 2014-07-01 – 2015-03-31 | 128452000 | USD | 20160506 | Open filing evidence |
| 2014-10-01 – 2014-12-31 | 35762000 | USD | 20160205 | Open filing evidence |
| 2014-07-01 – 2014-12-31 | 79509000 | USD | 20160205 | Open filing evidence |
| 2014-07-01 – 2014-09-30 | 43747000 | USD | 20151106 | Open filing evidence |
| 2013-07-01 – 2014-06-30 | 173537000 | USD | 20160826 | Open filing evidence |
| 2014-01-01 – 2014-03-31 | 43041000 | USD | 20150508 | Open filing evidence |
| 2013-07-01 – 2014-03-31 | 124396000 | USD | 20150508 | Open filing evidence |
| 2013-10-01 – 2013-12-31 | 39212000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-12-31 | 81355000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-09-30 | 42143000 | USD | 20141107 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 185171000 | USD | 20150911 | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 52796000 | USD | 20140509 | Open filing evidence |
| 2012-07-01 – 2013-03-31 | 141847000 | USD | 20140509 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 44320000 | USD | 20140207 | Open filing evidence |
| 2012-07-01 – 2012-12-31 | 89051000 | USD | 20140207 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 44731000 | USD | 2013-11-08 · 17:00:55.000Z | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 176141000 | USD | 20140905 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 193232000 | USD | 2013-08-29 · 16:01:07.000Z | Open filing evidence |
Operating Segments · Pharmaceutical Ingredients
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=acet:PharmaceuticalIngredientsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-03-31 | 43201000 | USD | 2018-10-12 · 21:03:09.000Z | Open filing evidence |
| 2017-07-01 – 2018-03-31 | 113406000 | USD | 2018-10-12 · 21:03:09.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 33629000 | USD | 2018-02-02 · 16:02:38.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 70205000 | USD | 2018-02-02 · 16:02:38.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 36576000 | USD | 2017-11-03 · 19:59:56.000Z | Open filing evidence |
| 2016-07-01 – 2017-06-30 | 157445000 | USD | 2017-11-09 · 22:17:24.000Z | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 43821000 | USD | 2018-10-12 · 21:03:09.000Z | Open filing evidence |
| 2016-07-01 – 2017-03-31 | 121253000 | USD | 2018-10-12 · 21:03:09.000Z | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 36816000 | USD | 2018-02-02 · 16:02:38.000Z | Open filing evidence |
| 2016-07-01 – 2016-12-31 | 77432000 | USD | 2018-02-02 · 16:02:38.000Z | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 40616000 | USD | 2017-11-03 · 19:59:56.000Z | Open filing evidence |
| 2015-07-01 – 2016-06-30 | 161011000 | USD | 2017-11-09 · 22:17:24.000Z | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 45841000 | USD | 2017-05-05 · 16:01:16.000Z | Open filing evidence |
| 2015-07-01 – 2016-03-31 | 118496000 | USD | 2017-05-05 · 16:01:16.000Z | Open filing evidence |
| 2015-10-01 – 2015-12-31 | 34295000 | USD | 2017-02-03 · 17:36:36.000Z | Open filing evidence |
| 2015-07-01 – 2015-12-31 | 72655000 | USD | 2017-02-03 · 17:36:36.000Z | Open filing evidence |
| 2015-07-01 – 2015-09-30 | 38360000 | USD | 20161103 | Open filing evidence |
| 2014-07-01 – 2015-06-30 | 149296000 | USD | 2017-11-09 · 22:17:24.000Z | Open filing evidence |
| 2015-01-01 – 2015-03-31 | 40548000 | USD | 20160506 | Open filing evidence |
| 2014-07-01 – 2015-03-31 | 111104000 | USD | 20160506 | Open filing evidence |
| 2014-10-01 – 2014-12-31 | 32579000 | USD | 20160205 | Open filing evidence |
| 2014-07-01 – 2014-12-31 | 70556000 | USD | 20160205 | Open filing evidence |
| 2014-07-01 – 2014-09-30 | 37977000 | USD | 20151106 | Open filing evidence |
| 2013-07-01 – 2014-06-30 | 176425000 | USD | 20160826 | Open filing evidence |
| 2014-01-01 – 2014-03-31 | 47843000 | USD | 20150508 | Open filing evidence |
| 2013-07-01 – 2014-03-31 | 133746000 | USD | 20150508 | Open filing evidence |
| 2013-10-01 – 2013-12-31 | 37479000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-12-31 | 85903000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-09-30 | 48424000 | USD | 20141107 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 184852000 | USD | 20150911 | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 61776000 | USD | 20140509 | Open filing evidence |
| 2012-07-01 – 2013-03-31 | 142169000 | USD | 20140509 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 39785000 | USD | 20140207 | Open filing evidence |
| 2012-07-01 – 2012-12-31 | 80393000 | USD | 20140207 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 40608000 | USD | 2013-11-08 · 17:00:55.000Z | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 162998000 | USD | 20140905 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 149340000 | USD | 2013-08-29 · 16:01:07.000Z | Open filing evidence |
Foreign Segment · US
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:ForeignSegmentMember;srt:StatementGeographicalAxis=country:US| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-07-01 – 2018-06-30 | 24950000 | USD | 2018-09-28 · 15:02:38.000Z | Open filing evidence |
| 2016-07-01 – 2017-06-30 | 21750000 | USD | 2018-09-28 · 15:02:38.000Z | Open filing evidence |
| 2015-07-01 – 2016-06-30 | 23810000 | USD | 2018-09-28 · 15:02:38.000Z | Open filing evidence |
Foreign Segment · United States Market
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:ForeignSegmentMember;us-gaap:StatementGeographicalAxis=acet:UnitedStatesMarketMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2012-07-01 – 2013-06-30 | 36976000 | USD | 2013-08-29 · 16:01:07.000Z | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 37892000 | USD | 2013-08-29 · 16:01:07.000Z | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 26775000 | USD | 2013-08-29 · 16:01:07.000Z | Open filing evidence |
Foreign Segment · US
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:ForeignSegmentMember;us-gaap:StatementGeographicalAxis=country:US| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2016-07-01 – 2017-06-30 | 21750000 | USD | 2017-11-09 · 22:17:24.000Z | Open filing evidence |
| 2015-07-01 – 2016-06-30 | 23810000 | USD | 2017-11-09 · 22:17:24.000Z | Open filing evidence |
| 2014-07-01 – 2015-06-30 | 38295000 | USD | 2017-11-09 · 22:17:24.000Z | Open filing evidence |
| 2013-07-01 – 2014-06-30 | 31156000 | USD | 20160826 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 36976000 | USD | 20150911 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 37892000 | USD | 20140905 | Open filing evidence |
Human Health
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:HumanHealthMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 84981000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 165827000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 80846000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 103466000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 209481000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 106015000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 36299000 | USD | 20130510 | Open filing evidence |
| 2012-07-01 – 2013-03-31 | 92559000 | USD | 20130510 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 29851000 | USD | 20130208 | Open filing evidence |
| 2012-07-01 – 2012-12-31 | 56260000 | USD | 20130208 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 26409000 | USD | 20121109 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 105249000 | USD | 20120907 | Open filing evidence |
| 2012-01-01 – 2012-03-31 | 28182000 | USD | 20130510 | Open filing evidence |
| 2011-07-01 – 2012-03-31 | 78243000 | USD | 20130510 | Open filing evidence |
| 2011-10-01 – 2011-12-31 | 27308000 | USD | 20130208 | Open filing evidence |
| 2011-07-01 – 2011-12-31 | 50061000 | USD | 20130208 | Open filing evidence |
| 2011-07-01 – 2011-09-30 | 22753000 | USD | 20121109 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 69856000 | USD | 20120907 | Open filing evidence |
| 2009-07-01 – 2010-06-30 | 47046000 | USD | 20120907 | Open filing evidence |
Human Health · Active Pharmaceutical Ingredients
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:HumanHealthMember;srt:ProductOrServiceAxis=acet:ActivePharmaceuticalIngredientsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
Human Health · Agricultural Protection Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:HumanHealthMember;srt:ProductOrServiceAxis=acet:AgriculturalProtectionProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
Human Health · Finished Dosage Form Generic Drugs
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:HumanHealthMember;srt:ProductOrServiceAxis=acet:FinishedDosageFormGenericDrugsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 73663000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 142876000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 69213000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 90761000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 186322000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 95561000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
Human Health · Nutraceutical Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:HumanHealthMember;srt:ProductOrServiceAxis=acet:NutraceuticalProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 11318000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 22951000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 11633000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 12705000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 23159000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 10454000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
Human Health · Pharmaceutical Intermediates
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:HumanHealthMember;srt:ProductOrServiceAxis=acet:PharmaceuticalIntermediatesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
Human Health · Specialty Chemicals
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:HumanHealthMember;srt:ProductOrServiceAxis=acet:SpecialtyChemicalsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
Performance Chemicals
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:PerformanceChemicalsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 36626000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 81337000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 44711000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 34134000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 76798000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 42664000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 52796000 | USD | 20130510 | Open filing evidence |
| 2012-07-01 – 2013-03-31 | 141847000 | USD | 20130510 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 44320000 | USD | 20130208 | Open filing evidence |
| 2012-07-01 – 2012-12-31 | 89051000 | USD | 20130208 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 44731000 | USD | 20121109 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 176141000 | USD | 20120907 | Open filing evidence |
| 2012-01-01 – 2012-03-31 | 52653000 | USD | 20130510 | Open filing evidence |
| 2011-07-01 – 2012-03-31 | 133659000 | USD | 20130510 | Open filing evidence |
| 2011-10-01 – 2011-12-31 | 44751000 | USD | 20130208 | Open filing evidence |
| 2011-07-01 – 2011-12-31 | 81006000 | USD | 20130208 | Open filing evidence |
| 2011-07-01 – 2011-09-30 | 36255000 | USD | 20121109 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 193232000 | USD | 20120907 | Open filing evidence |
| 2009-07-01 – 2010-06-30 | 163131000 | USD | 20120907 | Open filing evidence |
Performance Chemicals · Active Pharmaceutical Ingredients
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:PerformanceChemicalsMember;srt:ProductOrServiceAxis=acet:ActivePharmaceuticalIngredientsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
Performance Chemicals · Agricultural Protection Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:PerformanceChemicalsMember;srt:ProductOrServiceAxis=acet:AgriculturalProtectionProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 5044000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 13534000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 8490000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 3601000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 12245000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 8644000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
Performance Chemicals · Finished Dosage Form Generic Drugs
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:PerformanceChemicalsMember;srt:ProductOrServiceAxis=acet:FinishedDosageFormGenericDrugsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
Performance Chemicals · Nutraceutical Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:PerformanceChemicalsMember;srt:ProductOrServiceAxis=acet:NutraceuticalProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
Performance Chemicals · Pharmaceutical Intermediates
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:PerformanceChemicalsMember;srt:ProductOrServiceAxis=acet:PharmaceuticalIntermediatesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
Performance Chemicals · Specialty Chemicals
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:PerformanceChemicalsMember;srt:ProductOrServiceAxis=acet:SpecialtyChemicalsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 31582000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 67803000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 36221000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 30533000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 64553000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 34020000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
Pharmaceutical Ingredients
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:PharmaceuticalIngredientsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 42042000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 80890000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 38848000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 33629000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 70205000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 36576000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 61776000 | USD | 20130510 | Open filing evidence |
| 2012-07-01 – 2013-03-31 | 142169000 | USD | 20130510 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 39785000 | USD | 20130208 | Open filing evidence |
| 2012-07-01 – 2012-12-31 | 80393000 | USD | 20130208 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 40608000 | USD | 20121109 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 162998000 | USD | 20120907 | Open filing evidence |
| 2012-01-01 – 2012-03-31 | 40580000 | USD | 20130510 | Open filing evidence |
| 2011-07-01 – 2012-03-31 | 121537000 | USD | 20130510 | Open filing evidence |
| 2011-10-01 – 2011-12-31 | 38648000 | USD | 20130208 | Open filing evidence |
| 2011-07-01 – 2011-12-31 | 80957000 | USD | 20130208 | Open filing evidence |
| 2011-07-01 – 2011-09-30 | 42309000 | USD | 20121109 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 149340000 | USD | 20120907 | Open filing evidence |
| 2009-07-01 – 2010-06-30 | 136454000 | USD | 20120907 | Open filing evidence |
Pharmaceutical Ingredients · Active Pharmaceutical Ingredients
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:PharmaceuticalIngredientsMember;srt:ProductOrServiceAxis=acet:ActivePharmaceuticalIngredientsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 29510000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 58136000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 28626000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 23790000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 50230000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 26440000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
Pharmaceutical Ingredients · Agricultural Protection Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:PharmaceuticalIngredientsMember;srt:ProductOrServiceAxis=acet:AgriculturalProtectionProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
Pharmaceutical Ingredients · Finished Dosage Form Generic Drugs
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:PharmaceuticalIngredientsMember;srt:ProductOrServiceAxis=acet:FinishedDosageFormGenericDrugsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
Pharmaceutical Ingredients · Nutraceutical Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:PharmaceuticalIngredientsMember;srt:ProductOrServiceAxis=acet:NutraceuticalProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
Pharmaceutical Ingredients · Pharmaceutical Intermediates
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:PharmaceuticalIngredientsMember;srt:ProductOrServiceAxis=acet:PharmaceuticalIntermediatesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 12532000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 22754000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 10222000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 9839000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 19975000 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 10136000 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
Pharmaceutical Ingredients · Specialty Chemicals
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=acet:PharmaceuticalIngredientsMember;srt:ProductOrServiceAxis=acet:SpecialtyChemicalsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-10-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-12-31 | 0 | USD | 2019-02-20 · 12:01:29.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 0 | USD | 2018-11-09 · 16:01:55.000Z | Open filing evidence |